ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag funding immunology cancer evolution

One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
Immunology
The Scientist Staff | Mar 6, 1994 | 2 min read
J.G. Bodmer, S.G.E. Marsh, E.D. Albert, W.F. Bodmer, B. Dupont, H.A. Erlich, B. Mach, W.R. Mayr, P. Parham, T. Sasazuki, G.M.Th. Schreuder, J.L. Strominger, A. Svej-gaard, P.I. Terasaki, "Nomenclature for factors of the HLA system, 1991," Tissue Antigens, 39:161-73, 1992. Julia G. Bodmer (Tissue Antigen Laboratory, Imperial Cancer Research Fund, London): "`The dull catalogue of common things.' These words of the 19th-century English
Immunology
The Scientist Staff | Mar 6, 1994 | 2 min read
J.G. Bodmer, S.G.E. Marsh, E.D. Albert, W.F. Bodmer, B. Dupont, H.A. Erlich, B. Mach, W.R. Mayr, P. Parham, T. Sasazuki, G.M.Th. Schreuder, J.L. Strominger, A. Svej-gaard, P.I. Terasaki, "Nomenclature for factors of the HLA system, 1991," Tissue Antigens, 39:161-73, 1992. Julia G. Bodmer (Tissue Antigen Laboratory, Imperial Cancer Research Fund, London): "`The dull catalogue of common things.' These words of the 19th-century English
A Shot in the Arm
Edyta Zielinska | Jun 1, 2011 | 3 min read
Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.
A photo of King Charles III, then formally Prince of Wales, wearing a dark suit, shown from the shoulders up.
The Unscientific King: Charles III’s History Promoting Homeopathy
Sophie Fessl, PhD | Sep 29, 2022 | 6 min read
King Charles III has a long history of promoting homeopathic or alternative medical treatments not supported by scientific evidence.
A blood sample containing white and red blood cells.
Enhancing Cell Morphology-Based Analysis
The Scientist and Deepcell | Aug 3, 2023 | 3 min read
Learn how the latest AI-driven technology uses morphology to comprehensively analyze and sort cell populations.
Deciphering Immunology's Dirty Secret
Kate Travis | Jan 1, 2007 | 9 min read
Deciphering Immunology's Dirty Secret Can innate immune adjuvants save vaccinology? By Kate Travis ARTICLE EXTRAS 1 Why, he wondered, did scientists have to include bits of bacteria or aluminum hydroxide with a vaccine to get an immune response? Janeway hypothesized and later proved that so-called pattern recognition receptors identify invading pathogens and trigger an immediate reaction against the i
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
monoclonal antibody antibodies sars-cov-2 covid-19 coronavirus pandemic eli lilly receptor binding domain spike protein
First Antibody Trial Launched in COVID-19 Patients
Katarina Zimmer | Jun 2, 2020 | 8 min read
In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.
MMTV and Breast Cancer
Douglas Steinberg | Apr 16, 2000 | 7 min read
Virus-Disease Links Are Hard to Forge Researchers confront skepticism, conflicting results, limited funding By Douglas Steinberg If genomics is glitzy nowadays, virus research is, well, gritty. Its latest heyday, when HIV was shown to cause AIDS, only masked its true nature. Associating viruses with diseases has always been particularly difficult and labor intensive. Cause-and-effect relationships are maddeningly elusive.1 Consider the following two questions: Does infection by mouse mammary

Run a Search

ADVERTISEMENT